Title: Unlabeled Psilocybin and Psilocin Found in Mushroom-Infused Products, Raising Concerns
Introduction:
A recent study conducted by the University of Virginia Health Toxicology Laboratory revealed that several mushroom-infused products contain unlabeled psilocybin and psilocin, two illegal hallucinogenic substances. These products, marketed as mushroom-containing “nootropics” or cognitive enhancers, have raised concerns about potential health risks. The Centers for Disease Control and Prevention (CDC) warns that the presence of these substances in legally sold retail items represents a potential risk to the public.
The Study and Findings:
Researchers from the University of Virginia analyzed six packages of gummies from five different brands, purchased at gas stations and smoke shops near the Blue Ridge Poison Center. The brands tested were Diamond Shruumz Sour Peach Apple, Diamond Shruumz Rainbow, Urb Magic Amanita Mushroom Watermelon, Wonderland Legal Psychedelics Cherry Nirvana, Psilly’s Legal Psychedelic Mushrooms Fruit Punch, and Tryp mushroom gummies.
Four out of six bags tested contained unlabeled psilocybin or psilocin. The Diamond Shruumz Sour Peach Apple and Diamond Shruumz Rainbow products were found to contain psilocin, while Urb Magic Amanita Mushroom Watermelon contained both psilocybin and psilocin. Wonderland Legal Psychedelics Cherry Nirvana contained psilocin. Psilly’s Legal Psychedelic Mushrooms Fruit Punch contained ephedrine, a central nervous system stimulant, instead of psilocybin or psilocin. Tryp mushroom gummies were found to be accurately labeled.
Unlabeled Substances and Health Risks:
The study also revealed the presence of other unlabeled substances in some of the bags, including caffeine, ephedrine, and mitragynine (kratom) – a substance known to produce opioid and stimulant-like effects. The CDC cautions that the inaccurate labeling of these products raises concerns about unexpected and potentially toxic effects on consumers.
The Potential Dangers of Amanita Muscaria:
The study was prompted by the hospital evaluation of five individuals who ingested gummies labeled as containing Amanita muscaria, a legal mushroom with psychoactive properties. Although Amanita muscaria itself is legal, it contains the psychoactive substances ibotenic acid and muscimol. However, its use as a hallucinogen is less common due to the undesired symptoms it can cause, such as gastrointestinal upset, agitation, and seizures.
FDA Investigation and Recalls:
The U.S. Food and Drug Administration (FDA) is currently investigating reported illnesses of 69 people in 28 states that have been linked to the recalled Diamond Shruumz products. The recall was initiated due to higher than normal amounts of muscimol, a potent psychoactive compound found in certain mushrooms. Symptoms associated with the recalled items range from loss of consciousness and confusion to vomiting and seizures. One death potentially associated with the recalled items is also under investigation.
The Importance of Accurate Labeling:
The CDC highlights the potential risks to the public when products legally sold at retail shops contain unlabeled substances. Consumers should be cautious as labels may not accurately represent the contents, leading to unexpected and potentially toxic effects. The presence of mitragynine in one product is particularly concerning, as repeated ingestion can increase the risk for opioid dependence.
Manufacturer Response:
The CEO of LFTD, the parent company of Urb, stated that the gummies in question were discontinued in 2022 due to the market being flooded with illicit products falsely marketed as “amanita.” Counterfeit products may be responsible for the presence of psilocybin and psilocin in these gummies.
Conclusion:
The recent study conducted by the University of Virginia Health Toxicology Laboratory sheds light on the concerning presence of unlabeled psilocybin and psilocin in mushroom-infused products. The findings raise significant health risks for consumers, as inaccurate labeling can lead to unexpected and potentially toxic effects. The FDA’s ongoing investigation into the reported illnesses associated with the recalled Diamond Shruumz products further emphasizes the need for strict regulation and accurate labeling in the industry. Consumers must remain vigilant and informed about the contents of the products they purchase.
